"Given AstraZeneca's remarkable worldwide proficiency in clinical development and commercialization, the essential partnership between Eccogene and AstraZeneca will greatly expedite the development of ECC5004
Improved Patient Outcomes: By leveraging the strengths of multiple medications, combination therapy can improve overall glycemic control, reducing the risk of diabetes-related complications
This guide provides evidence-based recommendations for patients and clinicians navigating this common clinical scenario
Abstract Schisandra chinensis Fructus (SCF) is a traditional Chinese herbal medicine with both medicinal and culinary uses
The Non-Peptide GLP-1 Receptor Agonist WB4-24 Blocks Inflammatory Nociception by Stimulating -Endorphin Release From Spinal Microglia
Finally, administration of CBD intraperitoneally reduced proinflammatory cytokines in an animal model of ARDS induced by a viral mimetic [186], suggesting a potential benefit in the treatment of lung inflammation/injury from COVID-19